Moreover, in vivo depletion of human CD4+ T cells can efficiently reduce proinflammatory cytokine production and fibrosis in the humanized NASH mice, further confirming the importance of CD4+ T cells in the pathogenesis of NASH (65). This evidence concerns the gene CD4 and metabolic dysfunction-associated steatohepatitis.